Drug intelligence / Profile preview

(−)-[18F]flubatine

Development stage
Unknown
Lead developer
Helmholtz-Zentrum Dresden-Rossendorf
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

(−)-[18F]flubatine is a fluorine-18 labeled radiotracer and radioligand used for positron emission tomography (PET) imaging. It is a high-affinity ligand for the α4β2 subtype of brain nicotinic acetylcholine receptors (nAChRs). The compound enables visualization and quantification of these receptors in vivo, which is valuable for assessing cholinergic deficits in neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. Both enantiomers of flubatine bind specifically to α4β2 nAChRs; however, the (−) enantiomer demonstrates faster kinetics suitable for clinical PET imaging applications. The drug has been evaluated in early-phase clinical studies with no significant adverse effects observed in healthy volunteers[2][4].

Other names
Fluorine-18-flubatineFluorine18-flubatineFluorine 18-flubatineflubatine-[18F][18F]-norchloro-fluoro-homoepibatidine
02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)

Beyond the preview

Go deeper on (−)-[18F]flubatine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (−)-[18F]flubatine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call